Immix Biopharma
IMMX8.6902.00% ( +0.170 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Immix Biopharma(IMMX) predict that the EBIT is -10.8 M (--%), Beat estimate;the EPS is -0.18 (-20%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.01B--
-0.01B--
+0.00B--%
EPSExceed expectations
-0.1820.00%
-0.193328.89%
+0.01338.89%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf